Dentistry Dentistry
Bioactive Skin Regeneration
Support for Modern Dentistry
THERAVEX® supports oral tissue recovery by helping optimise the healing microenvironment after dental procedures and in selected oral conditions —designed for implantologists, oral surgeons, periodontists, and general dental practitioners who expect more from their post-procedure protocols.
Clinical Challenge
Oral tissues are constantly exposed to bacterial load, inflammation, mechanical stress, and post-procedure irritation. In implantology, oral surgery, periodontology, and mucositis management, recovery quality can influence patient comfort, tissue stability, and long-term clinical confidence.
How Theravex Helps
Theravex supports oral tissue recovery by helping optimise the healing microenvironment after dental procedures and in selected oral conditions —designed for implantologists, oral surgeons, periodontists, and general dental practitioners who expect more from their post-procedure protocols.
Applications

Oral surgery recovery

Dry socket support

Periodontal tissue recovery

Peri-implant tissue support

Bone grafting support environment

Post-procedure comfort

Oral mucositis support
Protocol A :Oral Surgery and Postoperative Oral Care
- Complete the planned dental or oral-surgical procedure using the clinician’s standard protocol.
- Use THERAVEX Tissue Care Plus intraoperatively when indicated by the approved professional protocol.
- For home oral care, use THERAVEX Oral Care as an undiluted rinse: 10–15 mL for at least 30 seconds, twice daily for seven days.
- Do not swallow. Avoid food or drink for 30 minutes after rinsing.
- Continue prescribed analgesia, antimicrobial treatment, oral hygiene, and follow-up; THERAVEX does not
replace them.
Protocol B : Implantology
- During surgery:
Apply 1 mL to the implant surface and 1 mL into the prepared socket, then place the implant according to the clinician’s standard surgical protocol. - Home recovery: THERAVEX Oral Care is used as the postoperative rinse according to the approved instructions.
- Follow-up:
Assess pain, soft-tissue recovery, wound-healing quality, implant stability, and complications at
the clinician’s usual review points.
Protocol C : Peri-Implantitis Procedure Support
- After appropriate decontamination and surgical management,
apply 1 mL to the implant surface and 1 mL into the
prepared site before implant placement or closure, as applicable. - Prescribe THERAVEX Oral Care for postoperative home recovery.
- THERAVEX does not replace mechanical debridement, infection control, or established periimplantitis
therapy.
Protocol D : Root-Canal Therapy
- Clean and disinfect the root canal using the clinician’s standard endodontic protocol.
- Apply 2 mL THERAVEX Tissue Care Plus inside the canal.
- Maintain contact for approximately one minute.
The source e-detailer describes up to one week in selected paediatric cases; this extended use must remain restricted to the verified-HCP protocol and requires
confirmation against local instructions before publication. - Dry and obturate using the clinician’s selected technique.
Protocol E : Periodontal and Mucogingival Surgery
- After root-surface debridement, apply 2 mL to the cleaned root surface and maintain contact for approximately
one minute. - When a graft is used, soak it in THERAVEX for approximately two minutes before placement.
- Proceed with graft placement and closure according to the surgical plan.
- Prescribe THERAVEX Oral Care for postoperative home recovery where appropriate
Following periodontal surgery, grafting, peri-implant procedures, or other mucosal interventions, integrate THERAVEX Oral Care into the postoperative plan. Continue mechanical plaque control, infection management, and periodontal maintenance as clinically indicated.
Key Benefit Pillars
One bioactive adjunct across hard- and soft-tissue procedures—supporting early oral wound healing, postoperative comfort, graft integration conditions, and implant stability within established dental protocols.
Evidence Highlight
- In a randomized, double-blind clinical trial of 81 patients, BBL/THERAVEX mouthwash was used twice daily for seven days after oral surgery and compared with 0.12% chlorhexidine.
- Pain improved in both groups, but the BBL group showed a statistically significant advantage beginning on Day 4.
- Early Healing Index scores at Day 7 were significantly higher with BBL; no adverse effects were reported in the study, while tooth staining occurred in the chlorhexidine group.
- In a randomized, double-blind implant study of 33 participants and 264 implants, THERAVEX-treated implants showed lower pain by Day 7, improved stability by Day 30, and a more favourable peri-implant bone-area response on CBCT by Day 60. These findings support an adjunctive healing claim, not a guarantee of osseointegration or bone regeneration.


